Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P36
Within normal range
vs 3Y Ago
-7.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -10.83% |
| 2024 | 18.18% |
| 2023 | -12.28% |
| 2022 | 1.39% |
| 2021 | 28.45% |
| 2020 | -2.75% |
| 2019 | -18.07% |
| 2018 | 56.71% |
| 2017 | 62.77% |
| 2016 | -50.86% |